Ralf Schirrmacher

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Topics

Positron Emission Tomography

Epidermal Growth Factor Receptor

Gold Nanoparticles

Top Venues

Pharmaceuticals (Basel, Switzerland)

EJNMMI radiopharmacy and chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α v β 3 Targeting. ACS omega 8 (2) (2023)
Simon Blok, Carmen Wängler, Peter Bartenstein, Klaus Jurkschat, Ralf Schirrmacher, Simon Lindner
Good practices for the automated production of 18 F-SiFA radiopharmaceuticals. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Güllü Davarci, Carmen Wängler, Klaus Eberhardt, Christopher Geppert, Ralf Schirrmacher, Robert Freudenberg, Marc Pretze, Björn Wängler
Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Güllü Davarci, Carmen Wängler, Klaus Eberhardt, Christopher Geppert, Ralf Schirrmacher, Robert Freudenberg, Marc Pretze, Björn Wängler
Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Benedikt Judmann, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α v β 3 Targeting. ACS omega 8 (2) (2023)
Helen Damerow, Xia Cheng, Valeska von Kiedrowski, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Toward Optimized 89 Zr-Immuno-PET: Side-by-Side Comparison of [ 89 Zr]Zr-DFO-, [ 89 Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [ 89 Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable? Pharmaceutics 14 (10) (2022)
Carmen Wängler, Leonie Beyer, Peter Bartenstein, Björn Wängler, Ralf Schirrmacher, Simon Lindner
Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [ 18 F]SiTATE PET. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Helen Damerow, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68 Ga Labeling and Complex Stability Characteristics with Established Chelators. ChemMedChem (2022)
Benedikt Judmann, Diana Braun, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors. ACS omega 7 (31) (2022)
Justin J Bailey, Melinda Wuest, Tamara Bojovic, Travis Kronemann, Carmen Wängler, Björn Wängler, Frank Wuest, Ralf Schirrmacher
On the Viability of Tadalafil-Based 18F-Radiotracers for In Vivo Phosphodiesterase 5 (PDE5) PET Imaging. ACS omega 6 (33) (2021)
Justin J Bailey, Melinda Wuest, Michael Wagner, Atul Bhardwaj, Carmen Wängler, Bjoern Wängler, John F Valliant, Ralf Schirrmacher, Frank Wuest
Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model. Journal of medicinal chemistry 64 (21) (2021)
Helen Damerow, Ralph Hübner, Benedikt Judmann, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Side-by-Side Comparison of Five Chelators for 89 Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability. Cancers 13 (24) (2021)
Ralph Hübner, Alexa Paretzki, Valeska von Kiedrowski, Marco Maspero, Xia Cheng, Güllü Davarci, Diana Braun, Helen Damerow, Benedikt Judmann, Vasileios Filippou, Clelia Dallanoce, Ralf Schirrmacher, Björn Wängler, Carmen Wängler
PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Lexi Gower-Fry, Travis Kronemann, Andreas Dorian, Yinglan Pu, Carolin Jaworski, Carmen Wängler, Peter Bartenstein, Leonie Beyer, Simon Lindner, Klaus Jurkschat, Björn Wängler, Justin J Bailey, Ralf Schirrmacher
Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Xia Cheng, Ralph Hübner, Valeska von Kiedrowski, Gert Fricker, Ralf Schirrmacher, Carmen Wängler, Björn Wängler
Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin αvβ3 and the MC1 Receptor-Suitable for the Specific Visualization of Melanomas? Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Marc Pretze, Valeska von Kiedrowski, Roswitha Runge, Robert Freudenberg, René Hübner, Güllü Davarci, Ralf Schirrmacher, Carmen Wängler, Björn Wängler
αvβ3-Specific Gold Nanoparticles for Fluorescence Imaging of Tumor Angiogenesis. Nanomaterials (Basel, Switzerland) 11 (1) (2021)
Ralph Hübner, Valeska von Kiedrowski, Vanessa Benkert, Björn Wängler, Ralf Schirrmacher, Roland Krämer, Carmen Wängler
Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Noeen Malik, Shreya Bendre, Ralf Schirrmacher, Paul Schaffer
Lewis Acid-Facilitated Radiofluorination of MN3PU: A LRRK2 Radiotracer. Molecules (Basel, Switzerland) 25 (20) (2020)
Thomas A Singleton, Hussein Bdair, Justin J Bailey, Sangho Choi, Arturo Aliaga, Pedro Rosa-Neto, Ralf Schirrmacher, Vadim Bernard-Gauthier, Alexey Kostikov
Efficient radiosynthesis and preclinical evaluation of [18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging. Journal of labelled compounds & radiopharmaceuticals 63 (3) (2020)
Benedikt Judmann, Diana Braun, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Korbinian Krieger, Björn Wängler, Ralf Schirrmacher, Carmen Wängler
Identification of a Suitable Peptidic Molecular Platform for the Development of NPY(Y1 )R-Specific Imaging Agents. ChemMedChem 15 (17) (2020)
Simon Lindner, Carmen Wängler, Justin J Bailey, Klaus Jurkschat, Peter Bartenstein, Björn Wängler, Ralf Schirrmacher
Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography. Nature protocols 15 (12) (2020)
Stephanie J Mattingly, Melinda Wuest, Eugene J Fine, Ralf Schirrmacher, Frank Wuest
Synthesis and in vivo evaluation of a radiofluorinated ketone body derivative. RSC medicinal chemistry 11 (2) (2020)
Ralf Schirrmacher, Justin J Bailey, Andrew V Mossine, Peter J H Scott, Lena Kaiser, Peter Bartenstein, Simon Lindner, David R Kaplan, Alexey Kostikov, Gert Fricker, Anne Mahringer, Pedro Rosa-Neto, Esther Schirrmacher, Carmen Wängler, Björn Wängler, Alexander Thiel, Jean-Paul Soucy, Vadim Bernard-Gauthier
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals (Basel, Switzerland) 12 (1) (2019)
Justin J Bailey, Lena Kaiser, Simon Lindner, Melinda Wüst, Alexander Thiel, Jean-Paul Soucy, Pedro Rosa-Neto, Peter J H Scott, Marcus Unterrainer, David R Kaplan, Carmen Wängler, Björn Wängler, Peter Bartenstein, Vadim Bernard-Gauthier, Ralf Schirrmacher
First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS chemical neuroscience 10 (6) (2019)
Vadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, Arturo Aliaga, Justin J Bailey, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Marilyn Grand'Maison, Pierre-Luc Rochon, Björn Wängler, Carmen Wängler, Peter Bartenstein, Alexey Kostikov, David R Kaplan, Gert Fricker, Pedro Rosa-Neto, Peter J H Scott, Ralf Schirrmacher
Identification of [18F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging. Journal of medicinal chemistry 61 (4) (2018)
Alicia Vall-Sagarra, Shanna Litau, Clemens Decristoforo, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging? Pharmaceuticals (Basel, Switzerland) 11 (3) (2018)
Marc Pretze, Andreas Hien, Matthias Rädle, Ralf Schirrmacher, Carmen Wängler, Björn Wängler
Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Imaging. Bioconjugate chemistry 29 (5) (2018)
Sheldon Berke, Anne-Larissa Kampmann, Melinda Wuest, Justin J Bailey, Britta Glowacki, Frank Wuest, Klaus Jurkschat, Ralf Weberskirch, Ralf Schirrmacher
18F-Radiolabeling and In Vivo Analysis of SiFA-Derivatized Polymeric Core-Shell Nanoparticles. Bioconjugate chemistry 29 (1) (2017)